Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
NVIDIA Corp. €151.32 €172.00
MongoDB Inc. €284.35 €304.90
Oracle Corp. €267.85 €307.76
Security Price Target price
Tesla Inc €307.45 €311.09
Kohl's Corp. €13.33 €7.33
Spielvgg Unterhaching Kgaa €2.46 €0.000

New Top predictions since last week

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2025-09-10

Financial analysis of Continental Airlines B

Financial Report Analysis for CALERES INC (CAL)

1. Executive Summary

  • Current Financial Position: CALERES INC reported revenue of $683.3 million and profit of $29.96 million for Q3 2025.
  • Key Findings:
    1. Revenue decreased compared to the previous year's same quarter ($683.3 million vs $658.5 million in Q3 2024, as per income statement data for the respective periods).
    2. Profit significantly decreased year-over-year ($29.96 million in Q3 2024 vs $6.71 million in Q3 2025).
    3. Cash and cash equivalents increased to $191.5 million as of Aug 02, 2025.
  • Overall Trend: The financial trend appears mixed, with revenue growth but significant profit decline.

2. Profitability Analysis

  • Revenue Trend: Revenue increased from $658.5 million in Q3 2024 to $683.3 million in Q3 2025.
  • Profit Trend: Profit decreased substantially from $29.96 million in Q3 2024 to $6.71 million in Q3 2025.
  • Profit Margins:
    • Gross profit margin decreased from 45.5% ($310.9 million/$683.3 million) in Q3 2024 to 43.4% ($285.8 million/$658.5 million) in Q3 2025.
    • Operating income margin decreased from 6.2% ($42.5 million/$683.3 million) in Q3 2024 to 1.4% ($9.3 million/$658.5 million) in Q3 2025.
  • Operating Efficiency: Selling, general, and administrative expenses remained relatively stable at around $268-269 million, indicating consistent operational costs.

3. Balance Sheet Strength

  • Assets: Total assets increased to $2.152 billion as of Aug 02, 2025, from $2.02 billion as of Aug 03, 2024.
  • Liabilities: Total current liabilities increased to $1.015 billion from $860.4 million year-over-year.
  • Equity: Stockholders' equity (including non-controlling interest) increased to $621.9 million from $613.5 million.
  • Liquidity: Cash and cash equivalents increased to $191.5 million from $51.8 million year-over-year, improving liquidity.
  • Solvency: The company's debt (lines of credit) increased significantly to $387.5 million from $146.5 million, potentially affecting solvency.

4. Cash Flow Assessment

  • Operating Cash Flow: Net cash provided by operating activities was $41.6 million in Q3 2025, down from $115.7 million in Q3 2024.
  • Investing Cash Flow: Net cash used in investing activities was $34.1 million in Q3 2025, slightly higher than $21.8 million in Q3 2024.
  • Financing Cash Flow: Net cash provided by financing activities was $154.2 million in Q3 2025, significantly improved from -$63.4 million in Q3 2024, mainly due to increased borrowing.
  • Cash Generation: The company generated $161.9 million in net cash during Q3 2025, significantly higher than $30.4 million in Q3 2024.

5. Growth and Investment

  • Capital Expenditures: Payments to acquire property, plant, and equipment increased to $32.9 million from $20.9 million year-over-year.
  • R&D Investments: Not directly available, but software payments increased to $1.2 million from $0.9 million.
  • Growth Trajectory: Revenue growth is positive, but profit decline indicates potential challenges.

6. Risk Factors

  • Financial Risks: Increased debt levels and declining profitability pose financial risks.
  • Concerning Trends: Significant decrease in net income and increased reliance on borrowing.
  • Financial Resilience: The company's cash position has improved, but high debt levels may strain future cash flows.

7. Valuation Context

  • Earnings Per Share (EPS): Diluted EPS decreased from $0.85 in Q3 2024 to $0.20 in Q3 2025.
  • Valuation Metrics: Not directly calculable without stock price data, which is null in the provided information.

8. Key Considerations

  • Key Factors for Investors:
    1. The significant decline in profitability despite revenue growth.
    2. Increased debt levels and potential impact on future cash flows.
    3. Improved cash and cash equivalents position.
  • Strengths: Increased revenue and improved cash position.
  • Challenges: Declining profitability and increasing debt.
  • Trends/Anomalies: The substantial year-over-year decrease in net income warrants further investigation into operational efficiencies and cost management.

Many tell you which stocks to buy.

We measure how often they are right!

Portfolios of our members

Halbleiter 1
Total
€25,286
Cash
€646.20
Performance (%)
-74.714%

Pros and Cons of these stocks (New Predictions)

AIA Group Ltd.

WKN: A1C7F3 / Name: AIA Group / Stock / Insurance / Large Cap /

Pros
1
Well known brand
1
Very good company culture
3
Could be very worthwhile Investment >20% year
Cons
Zalando SE

WKN: ZAL111 / Name: Zalando / Stock / Other Specialty Retailers / Large Cap /

Pros
7
Could be worthwhile Investment >10% per year
3
Revenue growth > 30% per year expected
2
Higher EBIT margin than peer group
Cons
2
Low dividend yield expected
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops S&P 500

Security Price Change(%) (%)
Centene Corp. €29.60 10.700%
Synopsys Inc. €364.10 9.600%
Micron Technology Inc. €130.38 8.980%
Warner Bros. Discovery Inc. €11.47 6.980%
Discovery Communications C €22.42 5.110%
Security Price Change(%) (%)
Oracle Corp. €267.85 -4.580%
Delta Air Lines Inc. €50.10 -4.540%
Fox Corp. B €44.80 -3.860%
Carmax Inc. ? -3.570%
Alliance Data Systems Corp. €54.86 -3.410%

Courses

sharewise advanced features:
sharewise advanced features
You learn how to find  the latest news and find great financial information about your stocks.
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.

For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Key figures for stocks: https://unsplash.com/@markusspiske?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText
Key figures for stocks
Keeping an eye on the various key figures is important. We tell you what they mean.

Predictions

buy
Coca-Cola Co.

Start price
Target price
Perf. (%)
€58.01
17:45
€68.38
11.09.26
0.05%
18:31

buy
PepsiCo Inc.

Start price
Target price
Perf. (%)
€123.02
17:45
€145.32
11.09.26
-0.21%
18:29

buy
Autozone Inc.

Start price
Target price
Perf. (%)
€3,733.0
17:30
€4,209.9
11.09.26
0.00%
17:45

buy
Chewy Inc

Start price
Target price
Perf. (%)
€30.62
16:45
€41.03
11.09.26
0.10%
18:32

Top News

News

Circle Drops 30% in a Month: Should You Still Hold the CRCL Shares?
Circle Drops 30% in a Month: Should You Still Hold the CRCL Shares?

Circle Internet Group CRCL shares have dropped 30.3% in the past month, underperforming both the Zacks Financial-Miscellaneous Services industry and the Zacks Finance sector. While the industry has

TVTX Stock Soars as FDA Waives Advisory Committee for Filspari sNDA
TVTX Stock Soars as FDA Waives Advisory Committee for Filspari sNDA

Travere Therapeutics TVTX announced that the FDA, following further review of the supplemental new drug application (sNDA) for Filspari (sparsentan) in focal segmental glomerulosclerosis ("FSGS")

Is Strategy Stock's 1.93X PB Still Worth it? Buy, Sell, or Hold?: https://staticx-tuner.zacks.com/images/articles/main/2e/87002.jpg
Is Strategy Stock's 1.93X PB Still Worth it? Buy, Sell, or Hold?

Strategy MSTR shares are currently overvalued, as suggested by the Value Score of F. In terms of price/book, Strategy is trading at 1.93X compared with MARA Holdings’ MARA 1.23X and Riot Platforms’

Is Now the Time to Buy Oracle Stock After Its Q1 Earnings-Fueled Run?
Is Now the Time to Buy Oracle Stock After Its Q1 Earnings-Fueled Run?

Oracle ORCL finds itself at an inflection point following extraordinary first-quarter fiscal 2026 results that sent its stock soaring 36% in a single day, marking the best performance since 1992.

Applied Digital Jumps 122% Year to Date: Buy, Sell or Hold the Stock?
Applied Digital Jumps 122% Year to Date: Buy, Sell or Hold the Stock?

Applied Digital APLD shares have appreciated 122.2% year to date (YTD) compared with the broader Zacks Finance sector’s return of 12.1% and the Zacks Financial – Miscellaneous Services industry’s

Implied Volatility Surging for BCB Bancorp Stock Options
Implied Volatility Surging for BCB Bancorp Stock Options

Investors in BCB Bancorp, Inc. BCBP need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 17, 2025 $5.00 Put had some of the highest implied

Shell Signs Long-Term U.S. LNG Supply Deal With Italian Firm Edison
Shell Signs Long-Term U.S. LNG Supply Deal With Italian Firm Edison

Shell plc SHEL, a British energy giant, announced that Edison, a leading Italian utility firm, has entered into a liquefied natural gas (LNG) sales and purchase agreement with its subsidiary, Shell

Rocket Lab Gains 6.3% in the Past Month: How to Play the Stock?
Rocket Lab Gains 6.3% in the Past Month: How to Play the Stock?

Shares of Rocket Lab USA, Inc. RKLB have gained 6.3% in the past month, against the 2.5% decline of the Zacks Aerospace-Defense Equipment industry. It also outperformed the Zacks Aerospace sector’s

Chips to Compression: Why NVDA Investors Shouldn't Overlook AROC
Chips to Compression: Why NVDA Investors Shouldn't Overlook AROC

It’s no secret that investors betting on the future of AI are pouring money into NVIDIA NVDA stock. The powerful chips that NVDA is making are being utilized to run AI models. As the world builds

Contest

Compete in Catch the Monkey ...

... and win a prize!

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren

Heibel Ticker

sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.

Kostenlos ausprobieren

Leeway

Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren